
Afore Capital
San Francisco pre-seed venture capital firm founded in 2016 by Anamitra Banerji and Gaurav Jain, managing more than $500 million.
Company Type
private
Founded
2016
Headquarters
San Francisco, California, USA
Employees
Approximately 15
Primary Market
United States
About Afore Capital
What does Afore Capital own?
Afore owns stakes in more than 200 portfolio startups rather than operating brands. Its notable investments include Hightouch, Modern Health, BenchSci, Neo Financial, and New Lantern, spanning software categories where it was the first institutional investor.
Is Afore Capital publicly traded?
No. Afore Capital is a private venture capital partnership. It has no public listing, and its returns flow to the limited partners in its funds.
Who founded Afore Capital?
Anamitra Banerji and Gaurav Jain co-founded Afore in 2016. Banerji was an early product manager at Twitter, and Jain was an early Android product manager at Google before becoming a principal at Founder Collective.
Where is Afore Capital headquartered?
Afore Capital is headquartered in San Francisco, California, USA, in the center of the startup market it invests in.
How many companies has Afore invested in?
The firm reports more than 200 portfolio companies across its four funds, with a collective valuation above $13.5 billion as of 2025.
Who owns Afore Capital?
Co-founders and managing partners Anamitra Banerji and Gaurav Jain control the management company. The funds are limited partnerships backed by institutional and individual limited partners.
What is pre-seed 2.0?
Pre-seed 2.0 is the strategy announced with Afore's $185 million Fund IV in February 2025. It splits investing into standard checks up to $2 million for founders with plans, and an eight-week Founders-in-Residence program backing entrepreneurs still searching for an idea.
History of Afore Capital
Afore Capital was founded in San Francisco in 2016 by Anamitra Banerji and Gaurav Jain. Banerji had been an early product manager at Twitter; Jain was among the first product managers on Google's Android team before becoming a principal at Founder Collective, where he built a reputation as one of the earliest institutional pre-seed investors.
The founding argument was contrarian for the time. In 2016, pre-seed was an informal space of small angel checks and accelerator programs. Afore's position was that the first check should be larger, up to $2 million, because meaningful early capital let founders build faster rather than spending the first year fundraising.
The first two funds proved the model. By the time the firm raised its $150 million Fund III in 2022, early portfolio companies including Modern Health, BenchSci, Neo Financial, and Hightouch were marking up, and the firm was returning capital to limited partners. It reported in 2025 that it had already distributed $47 million, one times its first fund, back to investors.
In February 2025, Afore announced Fund IV at $185 million alongside a refined strategy it calls pre-seed 2.0. The update splits investing into two tracks: standard checks of up to $2 million for founders with defined plans, and an eight-week Founders-in-Residence program that backs entrepreneurs still developing ideas, including people who have not yet left their jobs or finished university.
Brands Owned by Afore Capital
Afore Capital owns 1 brand in our database. Explore the ownership tree below — click categories to expand and see individual brands.
Afore Capital
private · Founded 2016 · San Francisco, California, USA
1
brands
Afore Capital Ownership: Pros & Cons
Advantages
- +Category-defining position in institutional pre-seed investing
- +Founder-operating credibility attracts product-led entrepreneurs
- +Lean partnership keeps fees efficient and decisions fast
- +Early portfolio outcomes validate the concentrated stage thesis
Considerations
- -Stage concentration exposes returns to early-market downturns
- -Pre-seed outcomes take a decade or more to fully realize
- -Key-person dependence on two founding partners
- -Larger funds moving earlier compress its differentiation
Frequently Asked Questions About Afore Capital
What does Afore Capital own?
Afore owns stakes in more than 200 portfolio startups rather than operating brands. Its notable investments include Hightouch, Modern Health, BenchSci, Neo Financial, and New Lantern, spanning software categories where it was the first institutional investor.
Is Afore Capital publicly traded?
No. Afore Capital is a private venture capital partnership. It has no public listing, and its returns flow to the limited partners in its funds.
Who founded Afore Capital?
Anamitra Banerji and Gaurav Jain co-founded Afore in 2016. Banerji was an early product manager at Twitter, and Jain was an early Android product manager at Google before becoming a principal at Founder Collective.
Where is Afore Capital headquartered?
Afore Capital is headquartered in San Francisco, California, USA, in the center of the startup market it invests in.
How many companies has Afore invested in?
The firm reports more than 200 portfolio companies across its four funds, with a collective valuation above $13.5 billion as of 2025.
Who owns Afore Capital?
Co-founders and managing partners Anamitra Banerji and Gaurav Jain control the management company. The funds are limited partnerships backed by institutional and individual limited partners.
What is pre-seed 2.0?
Pre-seed 2.0 is the strategy announced with Afore's $185 million Fund IV in February 2025. It splits investing into standard checks up to $2 million for founders with plans, and an eight-week Founders-in-Residence program backing entrepreneurs still searching for an idea.








